Strusi, Alessandro
Strusi, Alessandro
Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study
2024 Iacovelli, Roberto; Ciccarese, Chiara; Buti, S.; Zucali, P. A.; Fantinel, E.; Bimbatti, D.; Verzoni, E.; Accettura, C.; Bonomi, L.; Buttigliero, C.; Fornarini, G.; Pipitone, S.; Atzori, F.; Masini, C.; Massari, F.; Primi, F.; Strusi, Alessandro; Giudice, G. C.; Perrino, M.; Maruzzo, M.; Milella, M.; Giannarelli, Diana; Brunelli, M.; Procopio, G.; Tortora, Giampaolo
The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis
2024 Ciccarese, Chiara; Anghelone, A.; Stefani, Alessio; Cigliola, A.; Strusi, Alessandro; D'Agostino, F.; Bria, Emilio; Iacovelli, Roberto; Tortora, Giampaolo
Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives
2024 Bauckneht, M.; Ciccarese, Chiara; Laudicella, R.; Mosillo, C.; D'Amico, F.; Anghelone, A.; Strusi, Alessandro; Beccia, Viria; Bracarda, S.; Fornarini, G.; Tortora, Giampaolo; Iacovelli, Roberto
Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario
2023 Ciccarese, Chiara; Strusi, Alessandro; Arduini, Daniela; Russo, Pierluigi; Palermo, Giuseppe; Foschi, Nazario; Racioppi, Marco; Tortora, Giampaolo; Iacovelli, Roberto
Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers
2022 Iacovelli, Roberto; Arduini, Daniela; Ciccarese, Chiara; Pierconti, Francesco; Strusi, Alessandro; Piro, Geny; Carbone, Carmine; Foschi, Nazario; Daniele, Gennaro; Tortora, Giampaolo
| Data di pubblicazione | Titolo | Autore(i) | File |
|---|---|---|---|
| 1-gen-2024 | Avelumab Plus Intermittent Axitinib in Previously Untreated Patients with Metastatic Renal Cell Carcinoma. The Tide-A Phase 2 Study | Iacovelli, Roberto; Ciccarese, Chiara; Buti, S.; Zucali, P. A.; Fantinel, E.; Bimbatti, D.; Verzoni, E.; Accettura, C.; Bonomi, L.; Buttigliero, C.; Fornarini, G.; Pipitone, S.; Atzori, F.; Masini, C.; Massari, F.; Primi, F.; Strusi, Alessandro; Giudice, G. C.; Perrino, M.; Maruzzo, M.; Milella, M.; Giannarelli, Diana; Brunelli, M.; Procopio, G.; Tortora, Giampaolo | |
| 1-gen-2024 | The incidence and relative risk of major adverse cardiovascular events and hypertension in patients treated with immune checkpoint inhibitors plus tyrosine-kinase inhibitors for solid tumors: a systemic review and meta-analysis | Ciccarese, Chiara; Anghelone, A.; Stefani, Alessio; Cigliola, A.; Strusi, Alessandro; D'Agostino, F.; Bria, Emilio; Iacovelli, Roberto; Tortora, Giampaolo | |
| 1-gen-2024 | Theranostics revolution in prostate cancer: Basics, clinical applications, open issues and future perspectives | Bauckneht, M.; Ciccarese, Chiara; Laudicella, R.; Mosillo, C.; D'Amico, F.; Anghelone, A.; Strusi, Alessandro; Beccia, Viria; Bracarda, S.; Fornarini, G.; Tortora, Giampaolo; Iacovelli, Roberto | |
| 1-gen-2023 | Post nephrectomy management of localized renal cell carcinoma. From risk stratification to therapeutic evidence in an evolving clinical scenario | Ciccarese, Chiara; Strusi, Alessandro; Arduini, Daniela; Russo, Pierluigi; Palermo, Giuseppe; Foschi, Nazario; Racioppi, Marco; Tortora, Giampaolo; Iacovelli, Roberto | |
| 1-gen-2022 | Targeting hypoxia-inducible factor pathways in sporadic and Von Hippel-Lindau syndrome-related kidney cancers | Iacovelli, Roberto; Arduini, Daniela; Ciccarese, Chiara; Pierconti, Francesco; Strusi, Alessandro; Piro, Geny; Carbone, Carmine; Foschi, Nazario; Daniele, Gennaro; Tortora, Giampaolo |